13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001535610
Total reported value
$110.5M
$110.5M
33 檔
7.2%
At the close of Q4 2025, Sabby Management, LLC disclosed equity holdings valued at approximately $110.5M, spread across 33 reported holdings.
Sabby Management, LLC executed strategic sector rebalancing during Q4 2025, establishing 14 new positions while fully exiting 20 holdings and trimming 9 positions.
In terms of portfolio concentration, the top 5 core holdings (including ABIVAX SA, , EMPD) accounted for 7.2% of total reported equity market value during Q4 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Abivax SA | Stock-Other | 13.19% | -8.61% | — | |
| 2 | ✓ | Stock-Other | 9.61% | — | -25.27% | ||
| 3 | EMPD | Empery Digital Inc | Stock-Other | 9.54% | — | +51.90% | |
| 4 | BLNK | Blink Charging Co | Stock-Other | 8.67% | — | — | |
| 5 | ✓ | Bitcoin Depot Inc | Stock-Other | 7.90% | — | — | |
| 6 | ✓ | Gevo Inc | Stock-Other | 7.67% | -16.06% | EXIT | |
| 7 | ABVX | Abivax Sa-adr | Stock-Other | 5.79% | — | — | |
| 8 | LYRA | Lyra Therapeutics Inc | Stock-Other | 3.30% | -0.57% | EXIT | |
| 9 | TPST | Tempest Therapeutics Inc | Stock-Other | 3.13% | +0.18% | — | |
| 10 | ✓ | Stock-Other | 2.96% | — | +192.54% | ||
| 11 | SNES | Senestech Inc | Stock-Other | 2.75% | -3.82% | +195.39% | |
| 12 | ✓ | Stock-Other | 2.65% | -1.78% | EXIT | ||
| 13 | ✓ | Pop Culture Group Co LTD | Stock-Other | 2.46% | -2.25% | EXIT | |
| 14 | ZONE | Cleancore Solutions Inc-cl B | Stock-Other | 2.30% | — | — | |
| 15 | ✓ | Jiuzi Holdings Inc | Stock-Other | 1.99% | — | — | |
| 16 | ✓ | Zevra Therapeutics Inc | Stock-Other | 1.79% | -3.00% | — | |
| 17 | ✓ | Globavend Holdings LTD | Stock-Other | 1.57% | — | — | |
| 18 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 1.45% | +45.73% | +34.75% | |
| 19 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 1.40% | -16.20% | — | |
| 20 | ✓ | Tian Ruixiang Hldgs LTD | Stock-Other | 1.38% | — | — | |
| 21 | INM | Inmed Pharmaceuticals Inc | Stock-Other | 1.31% | -1.53% | -8.35% | |
| 22 | QM30 | Nova Minerals Ltd-adr | Stock-Other | 1.11% | — | — | |
| 23 | ✓ | Ishares Tr | Stock-Other | 0.98% | +11.16% | -7.67% | |
| 24 | NUWE | Nuwellis Inc | Stock-Other | 0.95% | — | +149.86% | |
| 25 | ✓ | Epicquest Educatn Grp Intl L | Stock-Other | 0.90% | — | -25.94% | |
| 26 | ✓ | Ishares Tr | Stock-Other | 0.85% | +12.02% | NEW | |
| 27 | ✓ | Reviva Pharmaceutcls Hldgs Inc | Stock-Other | 0.70% | — | +1452.08% | |
| 28 | BCTXZ | Briacell Therapeutics - 30 | Stock-Other | 0.47% | -0.31% | -28.98% | |
| 29 | PMCB | Pharmacyte Biotech Inc | Stock-Other | 0.44% | — | — | |
| 30 | BNBX | Bnb Plus CORP | Stock-Other | 0.41% | -0.10% | EXIT | |
| 31 | OGEN | Oragenics Inc | Stock-Other | 0.30% | — | +4.73% | |
| 32 | LMFA | Lm Funding America Inc | Stock-Other | 0.07% | — | -95.85% | |
| 33 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 0.01% | — | -7.19% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&P 500 Etf Tr Put Option | +14.3% | +34.75% | Add |
| 2 | ✓ | Ishares Tr | +3.3% | -7.67% | Trim |
| 3 | ✓ | Gevo Inc | +1.5% | +347.18% | Add |
| 4 | ✓ | +0.4% | +192.54% | Add | |
| 5 | SNES | Senestech Inc | +0.3% | +195.39% | Add |
| 6 | EMPD | Empery Digital Inc | +0.3% | +51.90% | Add |
| 7 | ✓ | Reviva Pharmaceutcls Hldgs Inc | +0.2% | +1452.08% | Add |
| 8 | NUWE | Nuwellis Inc | +0.1% | +149.86% | Add |
| 9 | ✓ | Zevra Therapeutics Inc | +0.1% | — | Unchanged |
| 10 | OGEN | Oragenics Inc | 0% | +4.73% | Add |
| 11 | BCTXZ | Briacell Therapeutics - 30 | 0% | -28.98% | Trim |
| 12 | LYRA | Lyra Therapeutics Inc | -0.2% | +37.25% | Add |
| 13 | INM | Inmed Pharmaceuticals Inc | -0.3% | -8.35% | Trim |
| 14 | ✓ | Epicquest Educatn Grp Intl L | -0.3% | -25.94% | Trim |
| 15 | ✓ | Pop Culture Group Co LTD | -0.7% | -22.08% | Trim |
| 16 | LMFA | Lm Funding America Inc | -0.8% | -95.85% | Trim |
| 17 | ✓ | Ishares Tr | -3.4% | -32.37% | Trim |
| 18 | ✓ | Eos Energy Enterprises Inc | -4.6% | -7.19% | Trim |
| 19 | ✓ | -7% | -25.27% | Trim | |
| 20 | SPY | State Street SPDR S&P 500 ETF Trust | — | EXIT | Sold out |
| 21 | ✓ | Abivax SA | — | NEW | New buy |
| 22 | BLNK | Blink Charging Co | — | NEW | New buy |
| 23 | ✓ | Bitcoin Depot Inc | — | NEW | New buy |
| 24 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 25 | EVEX | Eve Holding Inc | — | EXIT | Sold out |
| 26 | ✓ | Can Fite Biofarma LTD | — | EXIT | Sold out |
| 27 | ✓ | Oceanpal Inc C | — | EXIT | Sold out |
| 28 | BIAF | Bioaffinity Technologies Inc | — | EXIT | Sold out |
| 29 | TPST | Tempest Therapeutics Inc | — | NEW | New buy |
| 30 | ✓ | — | EXIT | Sold out | |
| 31 | ✓ | — | NEW | New buy | |
| 32 | ZONE | Cleancore Solutions Inc-cl B | — | NEW | New buy |
| 33 | ✓ | Jiuzi Holdings Inc | — | NEW | New buy |
| 34 | ✓ | Geovax Labs Inc | — | EXIT | Sold out |
| 35 | ✓ | Globavend Holdings LTD | — | NEW | New buy |
| 36 | ✓ | Vision Marine Technologies I | — | EXIT | Sold out |
| 37 | ✓ | Core Scientific Inc New | — | EXIT | Sold out |
| 38 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
| 39 | ✓ | Tian Ruixiang Hldgs LTD | — | NEW | New buy |
| 40 | ✓ | — | EXIT | Sold out | |
| 41 | QM30 | Nova Minerals Ltd-adr | — | NEW | New buy |
| 42 | ✓ | — | EXIT | Sold out | |
| 43 | SNGX | Soligenix Inc | — | EXIT | Sold out |
| 44 | AIM | Aim Immunotech Inc | — | EXIT | Sold out |
| 45 | PMCB | Pharmacyte Biotech Inc | — | NEW | New buy |
| 46 | BNBX | Bnb Plus CORP | — | NEW | New buy |
| 47 | TC | Token Cat LTD | — | EXIT | Sold out |
| 48 | ✓ | Bluejay Diagnostics Inc | — | EXIT | Sold out |
| 49 | ✓ | Rubico Inc | — | EXIT | Sold out |
| 50 | ACXP | Acurx Pharmaceuticals Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Sabby Management, LLC reported a total U.S. public equity portfolio value of $110.5M across 33 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
ABIVAX SA
市值: $2.2M
Top Position Liquidated / Trimmed
SPY
前期市值: $7.9M
During Q4 2025, Sabby Management, LLC's top holdings by market value included ABIVAX SA (13.2%)、 (9.6%)、EMPD (9.5%). The largest single position, ABIVAX SA, represented 13.2% of total portfolio value.
In Q4 2025, Sabby Management, LLC made 52 total portfolio adjustments, initiating 14 new buys, adding to 9 positions, trimming 9 holdings, and fully liquidating 20 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.